S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
Log in
NYSE:A

Agilent Technologies Stock Forecast, Price & News

$126.33
-0.67 (-0.53 %)
(As of 01/22/2021 04:22 PM ET)
Add
Compare
Today's Range
$126.30
Now: $126.33
$127.80
50-Day Range
$113.58
MA: $120.45
$128.15
52-Week Range
$61.13
Now: $126.33
$129.34
Volume1.44 million shs
Average Volume1.78 million shs
Market Capitalization$38.76 billion
P/E Ratio54.93
Dividend Yield0.61%
Beta1.04
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.
Agilent Technologies logo

MarketRank

Overall MarketRank

1.77 out of 5 stars

Computer And Technology Sector

142nd out of 1,506 stocks

Analytical Instruments Industry

4th out of 29 stocks

Analyst Opinion: 2.3Community Rank: 3.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
CUSIP00846U10
Phone800-227-9770
Employees16,400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.34 billion
Cash Flow$4.32 per share
Book Value$15.81 per share

Profitability

Net Income$719 million

Miscellaneous

Market Cap$38.76 billion
Next Earnings Date2/16/2021 (Estimated)
OptionableOptionable
$126.33
-0.67 (-0.53 %)
(As of 01/22/2021 04:22 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive A News and Ratings via Email

Sign-up to receive the latest news and ratings for A and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Agilent Technologies (NYSE:A) Frequently Asked Questions

How has Agilent Technologies' stock been impacted by COVID-19 (Coronavirus)?

Agilent Technologies' stock was trading at $68.84 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, A shares have increased by 83.5% and is now trading at $126.33.
View which stocks have been most impacted by COVID-19
.

Is Agilent Technologies a buy right now?

27 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 11 hold ratings and 16 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Agilent Technologies stock.
View analyst ratings for Agilent Technologies
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Agilent Technologies?

Wall Street analysts have given Agilent Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Agilent Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as Agilent Technologies' CEO?

6,978 employees have rated Agilent Technologies CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Agilent Technologies' employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Agilent Technologies' next earnings date?

Agilent Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Agilent Technologies
.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) released its quarterly earnings data on Sunday, November, 22nd. The medical research company reported $0.98 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.93 by $0.05. The medical research company had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.40 billion. Agilent Technologies had a return on equity of 21.02% and a net margin of 13.47%. During the same quarter in the previous year, the business posted $0.89 EPS.
View Agilent Technologies' earnings history
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies declared a quarterly dividend on Wednesday, November 18th. Stockholders of record on Tuesday, January 5th will be given a dividend of $0.194 per share on Wednesday, January 27th. This represents a $0.78 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend is Monday, January 4th. This is an increase from Agilent Technologies's previous quarterly dividend of $0.18.
View Agilent Technologies' dividend history
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies pays an annual dividend of $0.78 per share and currently has a dividend yield of 0.61%. Agilent Technologies does not yet have a strock track record of dividend growth. The dividend payout ratio of Agilent Technologies is 23.78%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 18.80% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.
View Agilent Technologies' dividend history.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies updated its FY 2021 After-Hours earnings guidance on Monday, November, 23rd. The company provided EPS guidance of 3.57-3.67 for the period, compared to the Thomson Reuters consensus estimate of $3.68. The company issued revenue guidance of $5.6-5.7 billion, compared to the consensus revenue estimate of $5.67 billion.

What price target have analysts set for A?

27 Wall Street analysts have issued 1 year price objectives for Agilent Technologies' stock. Their forecasts range from $30.70 to $132.00. On average, they anticipate Agilent Technologies' share price to reach $88.42 in the next twelve months. This suggests that the stock has a possible downside of 30.0%.
View analysts' price targets for Agilent Technologies
or view Wall Street analyst' top-rated stocks.

Who are some of Agilent Technologies' key competitors?

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), The Boeing (BA) and Skyworks Solutions (SWKS).

Who are Agilent Technologies' key executives?

Agilent Technologies' management team includes the following people:
  • Mr. Michael R. McMullen, CEO, Pres & Director (Age 60, Pay $2.96M)
  • Mr. Robert W. McMahon, Sr. VP & CFO (Age 52, Pay $2.16M)
  • Mr. Michael Tang, Sr. VP, Gen. Counsel & Sec. (Age 47, Pay $991.5k)
  • Mr. Jacob Thaysen, Sr. VP and Pres of Life Sciences & Applied Markets Group (Age 46, Pay $1.04M)
  • Mr. Rodney Gonsalves, Principal Accounting Officer, VP & Corp. Controller (Age 55)
  • Dr. Darlene J. S. Solomon, CTO & Sr. VP (Age 62)
  • Mr. Ankur Dhingra, VP of Investor Relations
  • Mr. Dominique P. Grau, Sr. VP of HR & Global Communications (Age 62)
  • Mr. Richard A. Burdsall, Sr. VP of Global Infrastructure Services (Age 58)
  • Ms. Yvonne Mackie, MD of UK & Ireland Operations and VP of HR - Europe

What is Agilent Technologies' stock symbol?

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Pendal Group Limited (0.30%), LGT Capital Partners LTD. (0.27%), Frontier Capital Management Co. LLC (0.12%), Harvey Investment Co. LLC (0.06%), DNB Asset Management AS (0.06%) and State of Alaska Department of Revenue (0.05%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Paul N Clark and Rodney Gonsalves.
View institutional ownership trends for Agilent Technologies
.

Which institutional investors are selling Agilent Technologies stock?

A stock was sold by a variety of institutional investors in the last quarter, including Pendal Group Limited, Hexavest Inc., Baldwin Brothers Inc. MA, State of Alaska Department of Revenue, Pacer Advisors Inc., S.E.E.D. Planning Group LLC, Hendley & Co. Inc., and Cypress Capital Group. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, and Rodney Gonsalves.
View insider buying and selling activity for Agilent Technologies
or view top insider-selling stocks.

Which institutional investors are buying Agilent Technologies stock?

A stock was bought by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Frontier Capital Management Co. LLC, Kestra Advisory Services LLC, Exchange Traded Concepts LLC, LGT Capital Partners LTD., IFM Investors Pty Ltd, Louisiana State Employees Retirement System, and ProVise Management Group LLC.
View insider buying and selling activity for Agilent Technologies
or or view top insider-buying stocks.

How do I buy shares of Agilent Technologies?

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Agilent Technologies' stock price today?

One share of A stock can currently be purchased for approximately $126.33.

How big of a company is Agilent Technologies?

Agilent Technologies has a market capitalization of $38.76 billion and generates $5.34 billion in revenue each year. The medical research company earns $719 million in net income (profit) each year or $3.28 on an earnings per share basis. Agilent Technologies employs 16,400 workers across the globe.

What is Agilent Technologies' official website?

The official website for Agilent Technologies is www.agilent.com.

How can I contact Agilent Technologies?

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 800-227-9770 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.